LFSC

Held by: NMBL

Category	US Equities - Industry Sector
Sponsor	F/m Investments
Fund Family
Index	-
Index Weighting
Active/Passive
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Expense	0.54%
Inverse/Leveraged
IPO	Oct 31, 2024

Asset Type	Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short	No / Yes

Tags	Developed
Tags	equity
Tags	innovation
Tags	healthcare
Tags	biotechnology
Tags	medical
Tags	pharmaceutical
Sector/Theme
Region
SMA20	-6.52%
SMA50	-10.34%
SMA200	1.26%

Return% 1Y	39.07%
Return% 3Y	-
Return% 5Y	-
Return% 10Y
Return% SI
Flows% 1M	0.80%
Flows% 3M	2.10%
Flows% YTD	9.54%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades

Total Holdings	39
AUM	113.72M
NAV/sh
52W High	48.78 -16.47%
52W Low	30.45 33.83%
Volatility	1.31% 1.31%
ATR (14)	0.78
RSI (14)	29.37
Beta	0.95
Rel Volume	0.00
Avg Volume	3.19K
Volume	0

Perf Week	-2.60%
Perf Month	-10.08%
Perf Quarter	-9.26%
Perf Half Y	7.40%
Perf YTD	11.29%
Perf Year	35.94%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Prev Close	40.75
Price	40.75
Change %	0.00%

Jan-22-26 12:51PM	FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer (Benzinga)
Jan-14-26 06:44AM	Travere Stock Slips After FDA Delays Review Of Key Kidney Drug (Benzinga)
Dec-31-25 11:00AM	Best-Performing Active ETFs of 2025 (Zacks)
Feb-04-25 10:15AM	Shining a Light on New Investment Opportunities: Small Caps Emerge from the Shadows at the Groundhog Investment Conference (Business Wire)
Oct-31-24 07:30AM	Emerald Advisers and F/m Investments Announce the Launch of the F/m Emerald Life Sciences Innovation ETF (LFSC) (Business Wire)

F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

open in yahoo | open in marketwatch | open in google

F/m Emerald Life Sciences Innovation ETF

Upgrade your Finviz experience